Preservative-free single dose inhaler system

Abstract
An aerosolization system includes a container that is configured to deliver a unit dosage of a liquid when squeezed a single time. The system also includes an aerosolizer that is constructed of a housing defining a mouthpiece, and an aerosol generator disposed in the housing. The aerosol generator includes a vibratable membrane having a front face and a rear face, and a vibratable element used to vibrate the membrane. Further, the housing includes an opening that is adapted to receive a unit dosage of the liquid from the container. The opening provides a liquid path to the rear face of the vibratable membrane.
Description
FIELD OF THE INVENTION

This invention relates generally to a single dose inhaler and insulin formation containers. The inhaler dispenses aerosolized pharmaceutical agents for local or systemic inhalation drug delivery to the lungs. The invention is particularly, but not exclusively, useful for delivery of preservative free doses of insulin for treating type I and/or type II diabetic patients.


BACKGROUND OF THE INVENTION

Various types of inhalers exist for aerosolizing liquids. For example, U.S. Pat. No. 5,586,550, incorporated herein by reference, describes an inhaler which comprises a dispensing apparatus in which a membrane with tapered apertures is vibrated such that liquid in contact with a rear face of the membrane is dispensed from a front face of the membrane as an aerosol.


While effective at nebulizing liquids, such inhalers may not be particularly suited for certain applications, such as aerosolizing unit doses of insulin for pulmonary delivery.


Hence, the invention provides inhalers for delivering doses in a repeatable and predictable fashion. As described hereinafter, the inhalers of the invention may find particular use in aerosolizing liquid insulin for pulmonary delivery.


BRIEF SUMMARY OF THE INVENTION

The invention provides various aerosolization systems, including containers for supplying liquid to inhalers, as well as methods for their use. In one exemplary embodiment, the invention provides an aerosolization system that comprises a squeezable container having a resilient container body. The container is configured to deliver a unit dosage of a liquid when squeezed a single time.


The system further includes an aerosolizer that comprises a housing defining a mouthpiece, and an aerosol generator disposed in the housing. The aerosol generator comprises a vibratable membrane having a front face and a rear face, and a vibratable element used to vibrate the membrane. Further, the housing includes an opening that is adapted to receive a unit dosage of the liquid from the container. The opening provides a liquid path to the rear face of the vibratable membrane.


In one aspect, the aerosolizer includes a hollow needle that is configured to pierce the squeezable container and to supply the liquid to the rear face of the vibratable membrane. Also, the squeezable container may comprise a blister containing a single unit dosage. For example, the blister may comprise a blow-fill-seal container that contains a preservative free solution. The blister may further comprise a squeezable body containing the solution, a twist off top and a tab adapted to display information about the solution.


In a further aspect, the single unit dosage has a concentration in the range from about 200 insulin units (“IU”)/ml to about 800 IU/ml.


In another embodiment, the container comprises a bottle containing of volume of the liquid. In one aspect, the bottle may include a metering valve that permits dispensing of a discrete droplet of the liquid each time the bottle is squeezed. In other cases, the size of the droplet may be controlled based at least in part on the diameter of the tip of the bottle and the viscosity of the liquid.


The invention further provides another aerosolization system that comprises a container in the form of an ampoule containing a capillary that holds a single unit dosage of a liquid. The system also includes an aerosolizer comprising a housing defining a mouthpiece, and an aerosol generator disposed in the housing. The aerosol generator comprises a vibratable membrane having a front face and a rear face, and a vibratable element used to vibrate the membrane. Also, the housing includes an opening that is adapted to receive a unit dosage of the liquid from the container. Further, the opening provides a liquid path to the rear face of the vibratable membrane.


In one particular aspect, the ampoule further comprises a snap-off top and a snap-off bottom. The capillary is sized such that surface tension in the capillary prevents leakage of the liquid after removal of the top but prior to removal of the bottom.


A further embodiment of the invention provides an aerosolization system having a container comprising a container body that holds a supply of liquid, and a plunger device that is movable to dispense a single unit dosage of a liquid from the container upon operation of the plunger device a set distance. An aerosolizer comprises a housing defining a mouthpiece, and an aerosol generator disposed in the housing. The aerosol generator comprises a vibratable membrane having a front face and a rear face, and a vibratable element used to vibrate the membrane. Further, the housing includes an opening that is adapted to receive a unit dosage of the liquid from the container. The opening provides a liquid path to the rear face of the vibratable membrane.


In one aspect, the container further includes a metering device that is rotated to control movement of the plunger in order to set a single unit dosage amount.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective, partial cut-away view of one embodiment of a dispensing apparatus and squeezable container according to the invention.



FIG. 2 is a more detailed view of the dispensing apparatus and container of FIG. 1.



FIG. 3 is illustrates the dispensing device of FIG. 1, showing a more detailed view of a seat for holding the container and a needle for supplying dispensed liquid to an aerosol generator.



FIG. 4 is a perspective view of another embodiment of a dispensing apparatus and an a squeezable bottle according to the invention.



FIG. 4A is a cross sectional schematic view of a portion of the bottle of FIG. 4 in a closed position.



FIG. 4B is a cross sectional schematic view of a portion of the bottle of FIG. 4 in an open position.



FIG. 5 illustrates another embodiment of a container for dispensing a unit volume of a liquid according to the invention.



FIG. 6 illustrates the container of FIG. 5 when dispensing a unit volume of liquid into the dispensing apparatus of FIG. 4.



FIG. 7 illustrates an embodiment of an ampoule for dispensing a unit volume of a liquid according to the invention.



FIG. 8 illustrates the ampoule of FIG. 7 with an end removed.



FIG. 9 illustrates the ampoule of FIG. 8 with the top end also removed and being deposited into a dispensing apparatus.



FIG. 10 illustrates another embodiment of a container for dispensing a unit volume of a liquid into the dispensing apparatus of FIG. 4.





DETAILED DESCRIPTION OF THE INVENTION

Certain aspects of the invention describe an aerosolizing apparatus comprising a housing defining a dispensing outlet, a vibratable membrane having a front face exposed at the outlet and a rear face for receiving a liquid to be dispensed, and a vibrating mechanism connected to the housing and operable to vibrate the membrane to dispense aerosol of the liquid through the membrane. A liquid delivery system is used to deliver a metered quantity of the liquid from to the rear face of the membrane. In this way, a metered quantity of liquid is dispensable at the outlet by operating the vibrating mechanism for an operating period sufficient to completely aerosolize the metered quantity of the rear face.


An advantage of such an apparatus is that it facilitates the dispensing of substantially all of the liquid coming into contact with the rear face of the membrane as a single dose, especially when the metered dose is relatively small in volume. By dispensing the entire dose, the membrane is essentially free of liquid from one dose to the next. In this way, it is thereby possible to avoid contact between liquid and ambient air during periods of non-use between successive uses. For pharmaceutical preparations this is particularly important since it may obviate the need for the use of preservatives in the liquid and avoids evaporative losses. For example, various preservative free insulin formulations that may be used include those described in copending U.S. application Ser. No. 13/004,662, entitled “Preservative Free Insulin Formulations and Systems and Methods for Aerosolizing” and filed on the same date as the present application, previously incorporated by reference.


The liquid supply system in one embodiment may comprise a deformable thin-wall blister which contains a pharmaceutical agent. The supply system further comprises a mechanical press configured to deform the thin-walled blister such that a single, preservative free unit dose is delivered. The press mechanism is provided with a dispensing station provided with a piercing needle operable to pierce the blister and release its content upon actuation.


In one aspect, the needle has two ends, with the first end protruding from the surface of the dispensing station and a second end extending to rear face of the aerosol generator. In use the blister is seated in the dispensing station and the press mechanism forces the blister toward the needle which pierces through the thin wall. In this way, the needle provides a conduit for moving the liquid from the blister to the rear face of the vibratable membrane. When the press mechanism is released the blister expands and returns to its natural position. This expansion creates a suction action which removes the liquid from the needle and prevents dry out and clogging.


In a further aspect, the blister has a bellows shaped geometry which can elastically expand and compress. The term elastically expand and compress includes when the blister is fully compressed the internal stresses are still within the elastic range of the material in use, thus, the blister can return to its natural position when the press mechanism is released. In one particular aspect, the pharmaceutical agent fills at least 80% the internal volume of the blister and more preferably more than 90% of the volume. This prevents movement of liquid which in some cases may cause aggregation of the composition.


Conveniently, the end of the needle may be positioned in close proximity to the rear face of the vibratable membrane. Further, the housing may define a duct communicating between an air inlet and an outlet port. The dispensing outlet is located in the duct intermediate the air inlet and the outlet port such that the front face of the membrane is exposed to air within the duct. The outlet port may be a mouthpiece for inhalation or an adapter for nasal use.


Such an arrangement is particularly useful in the administration of inhaled pharmaceutical liquid products where it is required that a fine aerosol of liquid be entrained in an inhaled air flow passing through the mouthpiece. One example of such a liquid is an insulin composition.


Referring now to FIG. 1, one embodiment of an inhaler will be described. FIG. 1 illustrates a partially cut-away view of the single-dose-inhaler 100 and a unit dose blister 201 package for supplying a metered quantity of insulin to the inhaler. Inhaler 100 comprises two subassemblies 102 and 112. The first subassembly 102 defines a compartment for the electronic circuitry and the batteries, and the second subassembly 112 defines a housing with a dispensing outlet 105 and contains a vibratable membrane aerosol generator 108 and a dispensing mechanism 104. Aerosol generator 108 has a front face exposed at the outlet duct 111 and a rear face 109 contacted in use by liquid to be dispensed. Aerosol generator 108 is connected to the housing of subassembly 112 and is operable to dispense the active pharmaceutical agent as an aerosol through the mouthpiece 105. Exemplary aerosol generators that may be used are also described in U.S. Pat. Nos. 5,164,740; 6,629,646; 6,926,208; 7,108,197; 5,938,117; 6,540,153; 6,540,154; 7,040,549; 6,921,020; 7,083,112; 7,628,339; 5,586,550; 5,758,637; 6,085,740; 6,467,476; 6,640,804; 7,174,888; 6,014,970; 6,205,999; 6,755,189; 6,427,682; 6,814,071; 7,066,398; 6,978,941; 7,100,600; 7,032,590; 7,195,011, incorporated herein by reference. These references describe exemplary aerosol generators, ways to manufacture such aerosol generators and ways to supply liquid to aerosol generators, and are incorporated by reference for at least these features. The aerosol generators may comprise vibratable membranes having tapered aperture with a size in the range from about 3 μm to about 8 μm, preferably from about 3 μm to about 6 μm, and in some cases around 4 μm. The membrane may be domed shaped and be vibrated by an annular piezoelectric element that circumscribes the apertures. The diameter of the membrane may be in the range from about 5 mm to about 8 mm. The membrane may also have a thickness in the range from about 50 microns to about 70 microns. Typically, the membrane will be vibrated at a frequency in the range from about 50 kHz to about 150 kHz.


Each time the dispensing system is operated it delivers a metered quantity of the liquid from the unit dose blister 201 to the rear face 109 of the aerosol generator. Hence, for each use a metered quantity of aerosolized pharmaceutical agent is dispensed at the mouthpiece outlet 105 by operation of the aerosol generator.


The blister 201 contains a predetermined volume of an active pharmaceutical agent to be dispensed. In one embodiment the blister 201 contains about 80 to about 120 micro-liters of insulin. The lower limit is typically at least about 15 micro-liters and the upper limit is typically about 1,000 micro-liters to about 2,000 micro-liters. One particularly useful range is about 80 micro-liters to about 120 micro-liters in a concentration of about 100 insulin units/ml or greater, and more preferably between about 200-800 units/ml, and in some cases as high as 2,500 units/ml. Blister 201 is made of thin-walled deformable material. Due to sensitivity of insulin to mechanical agitation, the blister 201 is filled-up to nearly its entire volume. Specifically, more than 80% of the volume is filled with insulin.


Inhaler 100 further includes a dispensing station configured to dispense the content of the blister 201 to the aerosol generator 108. The dispensing station includes a swivel arm member 104 and a blister seat 107. The blister seat 107 has a concave shape which may radially match the convex shape of the blister 201. The blister seat 107 further includes a hypodermic needle 112 which establishes a fluid passage from the blister to the vibrating aerosol generator 108. The needle 112 has two sections. The first section 112A extends from the dispensing seat and protrudes outwardly perpendicularly to blister seat 107. The second end 112B extends inwardly toward the aerosol generator 108 and is positioned in closed proximity to rear side of the vibrating membrane of aerosol generator 108. Typically, second end 112B will be less than 5 mm and more preferably less than 2 mm from the vibrating membrane of the aerosol generator 108. The hypodermic needle 112 may be made of stainless steel alloy type 316 with a gage size ranging from 22 gage to 26 gage. The first section 112A has a sharp slanted piercing tip. In use, blister 201 is placed upon the concave seat 107 and then the swivel arm 104 is rotated counter clockwise in the direction of arrow 115.


Conveniently, the force upon the swivel arm 104 may be applied by a thumb against the curved portion of the arm 104. This action forces the blister toward the piercing tip of the needle 112A which subsequently pierces the blister 201 and squeezes its content via the needle 112 through the outlet of the needle 112B and onto the aerosol generator 108. When the swivel arm 104 is fully depressed, the entire dose is delivered to the vibrating membrane of the aerosol generator 108.



FIG. 2 illustrates the vibrating membrane 109 of the aerosol generator 108 in greater detail. When the content of the blister 201 is fully dispensed an indicator light 120 starts to blink signaling to the patient that the inhaler 100 is ready for use. At any time shortly thereafter the patient may inhale through the mouthpiece 105. Patient inhalation is detected by a flow sensor which in turn activates the aerosol generator 108 to produce aerosol particles into the duct 111. Aerosol is entrained in the inhalation air flow in the direction shown by arrows 121 and flow via the respiratory system to the lungs of the patient. When the entire dose is aerosolized, which may take one or morel breaths, the “end-of-dose” indicator light 121 lights a second time to signal the patient that the entire dose has been delivered. Delivery of the entire dose is obtained when at least about 95% of the dose is delivered, more preferably 98% and most preferably when more than 99% of the dose is delivered. In one embodiment, the opening funnel to the aerosol generator is sufficiently large such that the liquid delivery to the aerosol generator is delivered in its entirety. To receive the dose, the patient may take several inhalations or a single inhalation depending on the volume delivered to the mesh and the patient's breathing capacity. Each inhalation should be a deep breath to assure that the aerosol reaches deeply to the lungs.


When the end-of-dose indicator light 120 is actuated following inhalation of the contents of blister 201, the empty blister may be removed and discarded. When the thumb pressure on the swivel arm 104 is release the blister expands to its original shape. Expansion creates a vacuum inside the blister 201 which draws back any adhered fluid from the needle back to the blister, thereby leaving the interior of the needle dry to prevent material dry-out and clogging. To further prevent possible bacterial contamination the internal and/or the external surfaces of the needle, needle 112 may be coated with silver, a silver based coating or the like.



FIG. 3 illustrates the concave seat 107 of the dispensing station in greater detail. Seat 107 is provided with holes 117 which provides access to the interior of the inhaler in the vicinity of the aerosol generator 108. This permits cleaning solvents and rinsing water to be supplied to the aerosol generator 108.



FIG. 4 provides an alternative delivery system for an inhaler 500 which utilizes a preservative free dispenser 550 and a nozzle 551 to dispense a volume of a preservative free pharmaceutical agent to the aerosol generator via an opening 501. Inhaler 500 can be constructed in a manner similar to inhaler 100 and may include a similar aerosol generator. Opening 501 has a funnel shape which tapers down to a small opening 502, thus forming a slope 503. Dispenser 550 is a uniform drop, preservative free dispenser which upon activation displaces a single drop through the tip of its nozzle 551. Preferably, the drop volume is smaller than about 200 micro-liters. A dose is dispensed by squeezing container 550 in a direction perpendicular to its longitudinal axis. Upon each actuation, a single drop of a fixed volume is displaced through the nozzle 551.


One exemplary dispenser is the Aptar OSD dispenser, developed by Ing. Erich Pfeiffer GmbH. Such a container is constructed of a squeeze bottle that is squeeze to dispense a droplet. When released, the nozzle prevents microbiological contaminants from entering into the remaining liquid. This is accomplished through a tip seal (see, for example, tip seal 560 of FIGS. 4A and 4B) that prevents back flow of liquid into the container. As shown in FIG. 4A, the tip sealing mechanism includes a spring 562 that keeps the tip seal 560 in place in a normally closed position. When squeezing the bottle, liquid passes between the seal 560 and a cap until sufficient pressure is created to overcome the force of the spring 562 (see FIG. 4B). In this way, a single droplet can be dispensed. After dispensing, the tip seal again closes to prevent liquids from moving back into the container. To relieve the accumulating vacuum within the bottle, a small hole is included in the side of the container to allow air into the spring chamber. Droplet size can be controlled based on several factors including top size and the viscosity of the liquid.


In use, nozzle 551 is aligned with the opening 501 such that the drop is dispensed to the slope 503 and flows through the opening 502 to the aerosol generator. Preferably, the angle of slope 503 is greater than about 30 degrees relative to the axis of the opening 502. The diameter of opening 501 is about 10 mm to about 15 mm and the diameter of opening 502 is at least about 5 mm. The pharmaceutical fluid in the preservative free dispenser 550 may be contained in a collapsible sack to prevent excessive agitation and which may damaged by mechanical sloshing. For example, proteins, such as insulin, may be sensitive to mechanical agitation. Use of a collapsible sack may limit undesirable agitation.


In another alternative embodiment, instead of using a container of the type described in FIG. 5, a container 600 could be used. Container 600 comprises a blister 602 manufactured using a blow-fill-seal process. Container 600 is similar to the container 201 of FIG. 1 in that when the blister 602 is squeezed a unit dosage amount is delivered.


Blister 602 comprises a squeezable body 604 having a tab 606 and a twist off top 608. Body 604 is sized to hold a unit dosage of liquid, and tab 66 may include various types of identifying information, such as the lot number, date, and the like. Twist off top 608 provides a easy way to open blister 602 so that the liquid can be dispensed.


Referring also to FIG. 6, use of blister 602 in supplying a unit dose of liquid to inhaler 500 will be described. When ready to receive a treatment, a user takes blister 602 and twists off top 608. Typically, blister 602 will be held upright so that no liquid escapes. In some cases, the opening formed when top 608 is removed may be sized small enough to hinder liquid from escaping. Blister 602 is moved over opening 501 and body 604 is squeezed to expel the complete volume of liquid 610 into opening 501 where the liquid drains through opening 503 and to the aerosolizer. In this way, blister 602 functions as a hand squeezable, single use container for a preservative free solution. Use of a blow-fill-seal process is particularly advantageous in that the blister 602 can be manufactured at low cost while still allowing the storage of a preservative free solution. Also, the metering process is simple, requiring only the removal of the top and squeezing of the blister.



FIG. 7 illustrates an embodiment of an ampoule 700 for dispensing a unit volume of a liquid to be aerosolized. Ampoule 700 comprises an elongate body 702 defining a capillary that hold a unit volume of liquid 704. Ampoule 700 further includes a top end 706 and a bottom end 708 that may be removed from body 702, such as by snapping them off. Body 702 may be constructed of a generally rigid material that has sufficient rigidity to permit the two ends to be easily snapped off.


When ready to dispense the liquid into an inhaler, top end 706 is removed as illustrated in FIG. 8. The surface tension in body 702 prevents leakage of any liquid 704 when ampoule 700 is inverted, such as when inserting ampoule 700 into an inhaler.



FIG. 9 illustrates the ampoule of FIG. 8 after being inserted into an inhaler 720. Inhaler 720 may be constructed in a manner similar to the other embodiments described herein an includes electronics 722 that are employed to control operation of an aerosol generator 724 having a vibratable mesh 726. Inhaler 720 includes an elongate opening 730 into which ampoule 700 is inserted after end 706 is removed. Once in place, end 708 is snapped off which allows liquid 704 to drain from ampoule 700 and onto the rear face of vibratable mesh 726 as illustrated in FIG. 9. As mesh 726 vibrates, the liquid is aerosolized and directed toward a mouthpiece 732 where the patient can inhale the medicament. Following aerosolization, ampoule 700 may be removed from inhaler 720 and discarded.



FIG. 10 illustrates another embodiment of a container 800 for dispensing a unit volume of a liquid into the dispensing apparatus 500 that was previously described in connection with FIG. 4. Container 800 comprises a container body 802 defining a reservoir 804 for holding a volume of liquid to be dispensed. A plunger 806 is employed to force liquid in reservoir 804 through a dispensing end 808 of container 800. Container 800 also includes a geared metering mechanism 812 that is rotated or “dialed” in order to control the extent of movement of plunger 806. Further, an actuator 814 is pressed to move the plunger 806 by the amount permitted by metering mechanism 812. In this way, a user can simply “dial a dose” of liquid using metering mechanism 812 and then press actuator 814 in order to dispense a metered amount of liquid into hole 501 where it will be supplied to the aerosolization mechanism.


Container 800 can be configured to be disposable or reusable. When reusable, reservoir 804 may comprise a cartridge that is inserted into the space defined by reservoir 804. Exemplary volume sizes may be about 1, 1.8 or 3 ml cartridges, which may be constructed of glass, LDPE or the like.


The invention has now been described in detail for purposes of clarity and understanding. However, it will be appreciated that certain changes and modifications may be practiced within the scope of the appended claims.

Claims
  • 1. An aerosolization system, comprising: a housing comprising two lateral faces and a plurality of side walls extending between the two lateral faces, the housing defining a mouthpiece on one of the plurality of side walls and a liquid receptacle fluidly coupled to the mouthpiece, wherein the liquid receptacle defines an opening that extends through an exterior surface of one of the plurality of side walls of the housing at an inlet end of the opening and that is configured to receive a dosage of liquid from a tip of a container that is interfaced with the liquid receptacle such that at least a portion of the tip of the container is received within the liquid receptacle while a main body of the container remains external to the housing;an aerosol generator disposed within the housing, wherein during use the aerosol generator aerosolizes the dosage of liquid as a user inhales, the aerosol generator comprises: a membrane having a front face, a rear face, and a plurality of apertures that extend between the front face and the rear face, wherein the dosage of liquid is received onto the rear face of the membrane; anda vibratable element configured to vibrate the membrane to aerosolize the dosage of liquid;a flow sensor configured to detect fluid flow through the mouthpiece as a user inhales;a first light configured to indicate that the dosage of liquid has been manually dispensed from the tip of the container into a receiving chamber within the housing while the main body of the container remains external to the housing;a second light configured to indicate that the vibratable element has aerosolized the dosage of liquid and the entire dosage of liquid has been delivered to a user, wherein: the first and second lights are on a flat surface of one of the plurality of side walls of the housing aligned with the mouthpiece;delivery of the entire dosage comprises delivery of 98% or more of the liquid received onto the rear face of the membrane;the inlet end of the opening is positioned between, and in general alignment with, the mouthpiece and the first and second lights, with the first light, second light, and the opening being positioned on a same one of the plurality of side walls and the first light and the second light being oriented such that the first light and the second light are visible to the user while the user inhales through the mouthpiece; anda common plane that is generally parallel to the two lateral faces passes through each of the inlet end of the opening, an opening of the mouthpiece, and the first and second lights; anda controller coupled to the flow sensor and to the aerosol generator, wherein the controller activates the aerosol generator in response to a signal from the flow sensor indicating fluid flow through the mouthpiece, and wherein during use the controller activates the first light once the dosage of liquid is within the receiving chamber and the second light once the dosage of liquid is aerosolized and inhaled by the user.
  • 2. The aerosolization system of claim 1, wherein the first light blinks to indicate that the dosage of liquid is within the housing.
  • 3. The aerosolization system of claim 1, wherein the vibratable element vibrates the membrane from about 50 kHz to about 150 kHz.
  • 4. The aerosolization system of claim 3, wherein the second light blinks to indicate that the aerosol generator has aerosolized the dosage of liquid and the entire dosage of liquid has been delivered to the user.
  • 5. The aerosolization system of claim 1, wherein the liquid receptacle comprises a tapered wall that guides the dosage of liquid to the opening.
  • 6. The aerosolization system of claim 5, wherein the opening has an axis, and wherein the slope of the tapered wall is from 30 degrees to greater than perpendicular relative to the axis of the opening.
  • 7. The aerosolization system of claim 1, comprising a cover coupled to the housing, wherein the cover is configured to open and close to expose and cover the opening in the liquid receptacle.
  • 8. The aerosolization system of claim 1, wherein the liquid receptacle has a maximum receptacle diameter between about 10 mm to about 15 mm, and wherein the opening has a diameter of at least 5 mm.
  • 9. The aerosolization system of claim 1, comprises a bottle containing one or more dosages of liquid, and wherein the bottle is configured to dispense the dosage of liquid when the bottle is actuated.
  • 10. An aerosolization system, comprising: a housing comprising two lateral faces and a plurality of side walls extending between the two lateral faces, the housing defining a mouthpiece on one of the plurality of side walls and a liquid receptacle fluidly coupled to the mouthpiece, wherein the liquid receptacle defines an opening that extends through an exterior surface of one of the plurality of side walls of the housing at an inlet end of the opening and that is configured to receive a dosage of liquid from a tip of a container that is interfaced with the liquid receptacle such that at least a portion of the tip of the container is received within the liquid receptacle while a main body of the container remains external to the housing;an aerosol generator disposed within the housing, wherein the aerosol generator comprises: a membrane having a front face, a rear face, and a plurality of apertures that extend between the front face and the rear face, wherein the dosage of liquid is received onto the rear face of the membrane; anda vibratable element configured to vibrate the membrane to aerosolize the dosage of liquid;a first light configured to indicate that the dosage of liquid has been received within the housing from the tip of the container into a receiving chamber within the housing while the main body of the container remains external to the housing;a second light configured to indicate that the dosage of liquid has been aerosolized and that the entire dosage of liquid has been delivered to a user, wherein: the first and second lights are on a flat surface of one of the plurality of side walls of the housing aligned with the mouthpiece;delivery of the entire dosage comprises delivery of 98% or more of the liquid received onto the rear face of the membrane;the inlet end of the opening is positioned between, and in general alignment with, the mouthpiece and the first and second lights, with the first light, second light, and the opening being positioned on a same one of the plurality of side walls and the first light and the second light being oriented such that the first light and the second light are visible to the user while the user inhales through the mouthpiece; anda common plane that is generally parallel to the two lateral faces passes through each of the inlet end of the opening, an opening of the mouthpiece, and the first and second lights; anda controller coupled to the first light, wherein during use the controller activates the first light once the dosage of liquid is within the housing, and the second light when the entire dosage of liquid has been delivered to the user.
  • 11. The aerosolization system of claim 10, comprising a flow sensor coupled to the controller and configured to detect fluid flow through the mouthpiece as a user inhales, wherein the controller activates the aerosol generator in response to a signal from the flow sensor indicating fluid flow through the mouthpiece, wherein during use the vibratable element aerosolizes the dosage of liquid as the user inhales.
  • 12. The aerosolization system of claim 10, wherein the liquid receptacle comprises a tapered wall that guides the dosage of liquid to the opening.
  • 13. The aerosolization system of claim 10, comprises a bottle containing one or more dosages of liquid, and wherein the bottle is configured to dispense the dosage of liquid when the bottle is actuated.
  • 14. An aerosolization system, comprising: a housing comprising two lateral faces and a plurality of side walls extending between the two lateral faces, the housing defining a mouthpiece on one of the plurality of side walls and a liquid receptacle fluidly coupled to the mouthpiece, wherein the liquid receptacle defines an opening that extends through an exterior surface of one of the plurality of side walls of the housing at an inlet end of the opening and that is configured to receive a dosage of liquid from a tip of a container that is interfaced with the liquid receptacle such that at least a portion of the tip of the container is received within the liquid receptacle while a main body of the container remains external to the housing;an aerosol generator disposed within the housing, wherein the aerosol generator comprises: a membrane having a front face, a rear face, and a plurality of apertures that extend between the front face and the rear face, wherein the dosage of liquid is received onto the rear face of the membrane; anda vibratable element configured to vibrate the membrane to aerosolize the dosage of liquid;a first light configured to indicate that the dosage of liquid has been manually dispensed from the tip of the container into a receiving chamber within the housing while the main body of the container remains external to the housing;a second light configured to indicate that the vibratable element has aerosolized the dosage of liquid and the entire dosage of liquid has been delivered to a user, wherein: the first and second lights are on a flat surface of one of the plurality of side walls of the housing aligned with the mouthpiece;delivery of the entire dosage comprises delivery of 99% or more of the liquid received onto the rear face of the membrane;the inlet end of the opening is positioned between, and in general alignment with, the mouthpiece and the first and second lights, with the first light, second light, and the opening being positioned on a same one of the plurality of side walls and the first light and the second light being oriented such that the first light and the second light are visible to the user while the user inhales through the mouthpiece; anda common plane that is generally parallel to the two lateral faces passes through each of the inlet end of the opening, an opening of the mouthpiece, and the first and second lights; anda controller coupled to the first light and the second light, wherein during use the controller activates the first light once the dosage of liquid is within the receiving chamber and the second light after the vibratable element has aerosolized the dosage of liquid and the entire dosage of liquid has been delivered to the user.
  • 15. The aerosolization system of claim 14, comprising a flow sensor coupled to the controller and configured to detect fluid flow through the mouthpiece as a user inhales, wherein the controller activates the aerosol generator in response to a signal from the flow sensor indicating fluid flow through the mouthpiece, wherein during use the vibratable element aerosolizes the dosage of liquid as the user inhales.
  • 16. The aerosolization system of claim 14, wherein the liquid receptacle comprises a tapered wall that guides the dosage of liquid to the opening.
  • 17. The aerosolization system of claim 14, comprises a bottle containing one or more dosages of liquid, and wherein the bottle is configured to dispense the dosage of liquid when the bottle is actuated.
CROSS-REFERENCES TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 14/606,623, filed on Jan. 27, 2015, which is a continuation of U.S. patent application Ser. No. 14/039,254, filed on Sep. 27, 2013, now U.S. Pat. No. 9,004,061, which is a continuation of U.S. patent application Ser. No. 13/004,662, filed on Jan. 11, 2011, now U.S. Pat. No. 8,950,394, which claims priority from U.S. Provisional Application No. 61/335,769, filed on Jan. 12, 2010, which are incorporated by reference herein in their entirety.

US Referenced Citations (97)
Number Name Date Kind
3789843 Armstrong et al. Feb 1974 A
4564129 Urban et al. Jan 1986 A
5060642 Gilman Oct 1991 A
5164740 Ivri Nov 1992 A
5261601 Ross et al. Nov 1993 A
5333106 Lanpher et al. Jul 1994 A
5347998 Hodson et al. Sep 1994 A
5363842 Mishelevich et al. Nov 1994 A
5364838 Rubsarnen Nov 1994 A
5479920 Piper et al. Jan 1996 A
5515842 Ramseyer et al. May 1996 A
5586550 Ivri et al. Dec 1996 A
5672581 Rubsamen et al. Sep 1997 A
5694919 Rubsamen et al. Dec 1997 A
5743250 Gonda et al. Apr 1998 A
5758637 Ivri et al. Jun 1998 A
5884620 Gonda et al. Mar 1999 A
5915378 Lloyd et al. Jun 1999 A
5938117 Ivri Aug 1999 A
5941240 Gonda et al. Aug 1999 A
6014970 Ivri et al. Jan 2000 A
6062212 Davison May 2000 A
6085740 Ivri et al. Jul 2000 A
6085753 Gonda et al. Jul 2000 A
6098615 Lloyd et al. Aug 2000 A
6131567 Gonda et al. Oct 2000 A
6205999 Ivri et al. Mar 2001 B1
6312665 Modi Nov 2001 B1
6408854 Gonda et al. Jun 2002 B1
6427682 Klimowicz et al. Aug 2002 B1
6467476 Ivri et al. Oct 2002 B1
6540153 Ivri Apr 2003 B1
6540154 Ivri et al. Apr 2003 B1
6629646 Ivri Oct 2003 B1
6640804 Ivri et al. Nov 2003 B2
6647987 Gonda et al. Nov 2003 B2
6688304 Gonda et al. Feb 2004 B2
6729327 McFarland, Jr. May 2004 B2
6755189 Ivri et al. Jun 2004 B2
6814071 Klimowic et al. Nov 2004 B2
6921020 Ivri Jul 2005 B2
6926208 Ivri Aug 2005 B2
6978941 Litherland et al. Dec 2005 B2
7028686 Gonda et al. Apr 2006 B2
7032590 Loeffler et al. Apr 2006 B2
7040549 Ivri et al. May 2006 B2
7066398 Borland et al. Jun 2006 B2
7083112 Ivri Aug 2006 B2
7100600 Loeffler et al. Sep 2006 B2
7108197 Ivri Sep 2006 B2
7117867 Cox et al. Oct 2006 B2
7174888 Ivri et al. Feb 2007 B2
7195011 Loeffler et al. Mar 2007 B2
7628339 Ivri et al. Dec 2009 B2
8950394 Patton et al. Feb 2015 B2
9004061 Patton et al. Apr 2015 B2
20010037805 Gonda et al. Nov 2001 A1
20010039948 Sexton et al. Nov 2001 A1
20020129813 Litherland Sep 2002 A1
20030019493 Narayan et al. Jan 2003 A1
20030072740 Milstein et al. Apr 2003 A1
20040134494 Papania et al. Jul 2004 A1
20040223917 Hindle et al. Nov 2004 A1
20040256488 Loeffler et al. Dec 2004 A1
20050011514 Power et al. Jan 2005 A1
20050030953 Vasudevan et al. Feb 2005 A1
20060239930 Lamche et al. Oct 2006 A1
20060261084 Grey et al. Nov 2006 A1
20070113841 Fuchs May 2007 A1
20070163572 Addington et al. Jul 2007 A1
20070209659 Ivri et al. Sep 2007 A1
20080020794 Garon et al. Jan 2008 A1
20080029083 Masada et al. Feb 2008 A1
20080060641 Smith et al. Mar 2008 A1
20080184993 Patel Aug 2008 A1
20080233053 Gross et al. Sep 2008 A1
20090025718 Denyer Jan 2009 A1
20090157037 Iyer et al. Jun 2009 A1
20090194104 Van Sickle Aug 2009 A1
20090241948 Clancy Oct 2009 A1
20090301472 Kim et al. Dec 2009 A1
20100075001 Succar et al. Mar 2010 A1
20100180890 Nobutani Jul 2010 A1
20100319686 Schennum Dec 2010 A1
20100326436 Kaneko Dec 2010 A1
20110114089 Andersen et al. May 2011 A1
20110168172 Patton et al. Jul 2011 A1
20110225008 Elkouh et al. Sep 2011 A1
20110253139 Guthrie et al. Oct 2011 A1
20120037154 Gallem et al. Feb 2012 A1
20120069803 Iwamura et al. Mar 2012 A1
20120155987 Watanabe Jun 2012 A1
20130155987 Lan et al. Jun 2013 A1
20140010187 Huang et al. Jan 2014 A1
20140362831 Young Dec 2014 A1
20150092590 Zhu et al. Apr 2015 A1
20150196721 Patton et al. Jul 2015 A1
Foreign Referenced Citations (12)
Number Date Country
2406684 Nov 2000 CN
2 835 435 Aug 2003 FR
9822290 May 1998 WO
03030829 Apr 2003 WO
2004028608 Apr 2004 WO
2006062449 Jun 2006 WO
2006006963 Jun 2006 WO
2007047948 Apr 2007 WO
2008121610 Oct 2008 WO
2009111612 Sep 2009 WO
2010002421 Jan 2010 WO
2010066714 Jun 2010 WO
Non-Patent Literature Citations (14)
Entry
Liu, F-Y, “Pulmonary Delivery of Free Liposomal Insulin,” Pharmaceutical Research, Kluwer Academic Publishers, New York, NY, vol. 10, No. 2, Feb. 1, 1993, 5 pages.
International Search Report and Written Opinion of PCT/US2011/020925 dated Mar. 14, 2011, 7 pages.
International Search Report and Written Opinion of PCT/US2011/020926 dated Mar. 14, 2011, 11 pages.
International Search Report and Written Opinion of PCT/US2013/034359 dated Jun. 28, 2013, 35 pages.
European Search Report of EP 11733287 dated Jul. 12, 2013, 12 pages.
European Search Report for European Patent Application 11733286.6, dated Aug. 4, 2015, 5 pages.
Australian Examination Report of related Australia application No. 2011205443 dated Mar. 13, 2015, 4 pages.
Office Action of related Chinese Application No. 201180005839.9 dated Jun. 17, 2014, 16 pages.
Office Action of related Chinese application No. 201180005839.9 dated Mar. 3, 2015, 13 pages.
Office Action of related Mexican application No. MX/a/2012/008010 dated Jul. 15, 2014, 5 pages.
Office Action of related Mexican Patent Application No. MX/a/2012/008010 dated Nov. 12, 2014, 6 pages.
Office Action of related Mexican Application No. MX/a/2012/008010 dated Feb. 12, 2015, 2 pages.
Office Action of related Russian Application No. 2012134422 dated Oct. 20, 2014, 5 pages.
EP Application No. 11733286.6 filed Jan. 12, 2011 received an Office Action dated Mar. 20, 2018, 4 pages.
Related Publications (1)
Number Date Country
20160271346 A1 Sep 2016 US
Provisional Applications (1)
Number Date Country
61335769 Jan 2010 US
Continuations (3)
Number Date Country
Parent 14606623 Jan 2015 US
Child 15165662 US
Parent 14039254 Sep 2013 US
Child 14606623 US
Parent 13004662 Jan 2011 US
Child 14039254 US